AMGN DCF Analysis: Intrinsic Value $296 vs Price $377

gurufocus.com · 2026-09-14

On September 14, 2026, we conducted a DCF analysis for Amgen Inc (AMGN) amidst a backdrop of fluctuating price performance. The stock has seen a significant dec

TickrTrends take: Amgen's current market price of $377 exceeds its calculated intrinsic value of $296 by a substantial margin, which aligns with TickrTrends' assessment that the stock is overvalued. For investors focused on valuation metrics, this gap suggests the stock is trading at a premium relative to its discounted cash flow analysis, a consideration particularly relevant in the Healthcare sector where valuation discipline can be important for long-term returns. Monitoring whether the company's fundamentals strengthen enough to justify the current price or whether the market reprices the stock toward its intrinsic value would be key factors for valuation-conscious observers.

Read the full story at gurufocus.com →